MENU
PL | PLN
PL | PLN
-
- Wszystkie wirówki
- Wirówki stołowe
- Wirówki podłogowe
- Wirówki z chłodzeniem
- Mikrowirówki
- Wirówki wielofunkcyjne
- Wirówki wysokoobrotowe
- Ultrawirówki
- Koncentrator
- Wyroby do diagnostyki in vitro
- Materiały zużywalne do wirówek wysokoobrotowych i ultrawirówek
- Probówki wirówkowe
- Płytki wirówkowe
- Oprogramowanie do zarządzania urządzeniami
- Zarządzanie próbkami i informacjami
-
- Wszystkie pipety, dozowniki oraz automatyczne urządzenia do pracy z cieczami
- Pipety mechaniczne
- Pipety elektroniczne
- Pipety wielokanałowe
- Pipety z wyporem bezpośrednim i dozowniki
- Końcówki do pipet
- Dozowniki butelkowe
- Pipetory
- Dozowniki i akcesoria do pipet
- Pipetowanie automatyczne
- Materiały eksploatacyjne do urządzeń automatycznych
- Akcesoria do urządzeń automatycznych
- Systemy do pracy z cieczami i serwisowanie pipet
Sorry, we couldn't find anything on our website containing your search term.
Sorry, we couldn't find anything on our website containing your search term.
Vaccine Research Discovered
Well thought-out tools for pharmaceutical and biotech laboratories
Read more
Read less
STRONG GROWING VACCINES
Protein subunit vaccines
Protein subunit vaccines (e.g., for influenza, hepatitis B and C) are a proven strategy for decades and still today in the spotlight for pandemic management.
➕ Require no production of the whole pathogen because the vaccine consists of immunogenic viral or bacterial fragments generated by recombinant protein techniques. Since non-pathogenic, they are considered as safe. Multiple expression systems for antigenic protein components such as yeast, bacteria, insect, mammalian, and plant cells, allow the production of large quantities and to address unmet needs.
➖ Establishment of a proper scale-up of antigen production can be a major constraint. Several booster doses and adjuvants are needed.
Protein subunit vaccines (e.g., for influenza, hepatitis B and C) are a proven strategy for decades and still today in the spotlight for pandemic management.
➕ Require no production of the whole pathogen because the vaccine consists of immunogenic viral or bacterial fragments generated by recombinant protein techniques. Since non-pathogenic, they are considered as safe. Multiple expression systems for antigenic protein components such as yeast, bacteria, insect, mammalian, and plant cells, allow the production of large quantities and to address unmet needs.
➖ Establishment of a proper scale-up of antigen production can be a major constraint. Several booster doses and adjuvants are needed.
Warto przeczytać
Virus-like particle vaccines
Virus-like particle vaccines are self-assembled viral structural proteins that mimic the native virus. This feature enables to trigger strong immune responses.
➕ Lacking the viral genome, the safety profile is excellent. The production is scalable and safe as no living virus or inactivation steps are involved.
➖ The particle assembly is sometimes challenging, the manufacturing process complicated.
Virus-like particle vaccines are self-assembled viral structural proteins that mimic the native virus. This feature enables to trigger strong immune responses.
➕ Lacking the viral genome, the safety profile is excellent. The production is scalable and safe as no living virus or inactivation steps are involved.
➖ The particle assembly is sometimes challenging, the manufacturing process complicated.
Warto przeczytać
IMPROVE YOUR RECOMBINANT PROTEIN VACCINE DISCOVERY
Warto przeczytać
*All products are for Research Use Only (RUO).
Warto przeczytać
DOWNLOADS
Application Note
Application Note
White Paper
Warto przeczytać